We've found
14,731
archived clinical trials in
Psychiatric
We've found
14,731
archived clinical trials in
Psychiatric
Engineering an Online STI Prevention Program
Updated: 12/31/1969
Engineering an Online STI Prevention Program
Status: Enrolling
Updated: 12/31/1969
Engineering an Online STI Prevention Program
Updated: 12/31/1969
Engineering an Online STI Prevention Program
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Engineering an Online STI Prevention Program
Updated: 12/31/1969
Engineering an Online STI Prevention Program
Status: Enrolling
Updated: 12/31/1969
Engineering an Online STI Prevention Program
Updated: 12/31/1969
Engineering an Online STI Prevention Program
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Engineering an Online STI Prevention Program
Updated: 12/31/1969
Engineering an Online STI Prevention Program
Status: Enrolling
Updated: 12/31/1969
Engineering an Online STI Prevention Program
Updated: 12/31/1969
Engineering an Online STI Prevention Program
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment
Updated: 12/31/1969
Validation and Mapping of the Suicide Ideation and Behavior Assessment Tool in Subjects at Various Levels of Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment
Updated: 12/31/1969
Validation and Mapping of the Suicide Ideation and Behavior Assessment Tool in Subjects at Various Levels of Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment
Updated: 12/31/1969
Validation and Mapping of the Suicide Ideation and Behavior Assessment Tool in Subjects at Various Levels of Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment
Updated: 12/31/1969
Validation and Mapping of the Suicide Ideation and Behavior Assessment Tool in Subjects at Various Levels of Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment
Updated: 12/31/1969
Validation and Mapping of the Suicide Ideation and Behavior Assessment Tool in Subjects at Various Levels of Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment
Updated: 12/31/1969
Validation and Mapping of the Suicide Ideation and Behavior Assessment Tool in Subjects at Various Levels of Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment
Updated: 12/31/1969
Validation and Mapping of the Suicide Ideation and Behavior Assessment Tool in Subjects at Various Levels of Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment
Updated: 12/31/1969
Validation and Mapping of the Suicide Ideation and Behavior Assessment Tool in Subjects at Various Levels of Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cord Blood Infusion for Children With Autism Spectrum Disorder
Updated: 12/31/1969
Efficacy of Intravenous Umbilical Cord Blood Infusion as Cell Therapy for Children With Autism Spectrum Disorder (ASD): Duke ACT
Status: Enrolling
Updated: 12/31/1969
Cord Blood Infusion for Children With Autism Spectrum Disorder
Updated: 12/31/1969
Efficacy of Intravenous Umbilical Cord Blood Infusion as Cell Therapy for Children With Autism Spectrum Disorder (ASD): Duke ACT
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
To Evaluate the Efficacy of EEG-guided Magnetic Resonant Therapy in War Veterans With Posttraumatic Stress Disorder
Updated: 12/31/1969
A Pilot Study to Evaluate the Efficacy of EEG/ECG-guided Magnetic Resonant Therapy (MeRT) in War Veterans With Posttraumatic Stress Disorder (PTSD) at Tinker and MacDill Air Force Bases
Status: Enrolling
Updated: 12/31/1969
To Evaluate the Efficacy of EEG-guided Magnetic Resonant Therapy in War Veterans With Posttraumatic Stress Disorder
Updated: 12/31/1969
A Pilot Study to Evaluate the Efficacy of EEG/ECG-guided Magnetic Resonant Therapy (MeRT) in War Veterans With Posttraumatic Stress Disorder (PTSD) at Tinker and MacDill Air Force Bases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Updated: 12/31/1969
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials